Nicardipine Production Cost Reports

The report provides a detailed analysis essential for establishing a Nicardipine production plant. It encompasses all critical aspects necessary for Nicardipine production, including the cost of Nicardipine production, Nicardipine plant cost, Nicardipine production costs, and the overall Nicardipine production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Nicardipine production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Nicardipine is a dihydropyridine calcium channel blocker that treats hypertension and chronic stable angina. It stops calcium influx into vascular smooth muscle and myocardial cells, which leads to vasodilation, reduced peripheral resistance, and improved oxygen delivery to the heart without significant cardio-depressant effects. It is available in oral formulations to manage high blood pressure and chest pain. Its intravenous versions provide rapid control in hypertensive emergencies, postoperative hypertension, subarachnoid haemorrhage, and perioperative blood pressure fluctuations. It is taken 20-40 mg orally three times daily or 5 mg/hour IV infusion adjusted for renal and hepatic impairment.

The Nicardipine market growth is fuelled by the rising global burden of cardiovascular diseases like hypertension and angina. The rising geriatric populations expanded healthcare infrastructure in emerging economies, and demand for generics post-patent expiry contributes to its market growth. The advancements in drug formulations, combination therapies, hospital demand for IV injections in perioperative hypertension and critical care further boost its market.

The industrial Nicardipine procurement is influenced by regulatory compliance (like GMP, NMRA approvals), raw material cost volatility, and sterile production and storage requirements for injections. The pricing is further affected by generics and scale economies, supply chain resilience via diversified Indian and Chinese sourcing, and strategies like volume tenders, quality audits, etc.

Raw Material for Nicardipine Production

According to the Nicardipine production plant project report, the key raw material used in the production of Nicardipine includes Methyl ester of β-Aminocrotonic Acid, 2-Methyl-2-Benzylaminoethyl Ester of Acetoacetic Acid, and 3-Nitrobenzaldehyde.

Production Process of Nicardipine

The extensive Nicardipine production cost report consists of the following major industrial production process:

1. By Modified Hantzsch Dihydropyridine Synthesis: The production process of Nicardipine involves a modified Hantzsch dihydropyridine. The methyl ester of β-aminocrotonic works as the enamine component that reacts with 2-methyl-2-benzylaminoethyl ester of acetoacetic acid, which acts as the other β-ketoester. The heterocyclization takes place under reflux in a solvent like isopropanol with an excess of aldehyde. This leads to the formation of Nicardipine as the final product.

Nicardipine has the molecular formula of C26H29N3O6 and a molecular weight of 479.53 g/mol. It appears as a greenish-yellow, odourless crystalline solid or powder. It has a melting point at 136-138 degree Celsius (free base) or 169 degree Celsius (HCl salt). It shows low water solubility but shows good solubility in dichloromethane and methanol. It has a boiling point of 603.4 degree Celsius with a density of 1.23 g/cm³. It has a logP value of 3.82, indicating lipophilicity, and a pKa value of 7.3, and collision cross sections around 208-214 Ų. It contains a dihydropyridine ring, nitrophenyl substituent, and ester groups, and is stable under -20 degree Celsius storage with purity standards ≥98% for pharmaceutical use.